DaVita Inc. Files 8-K Reporting Other Events

Ticker: DVA · Form: 8-K · Filed: 2025-04-14T00:00:00.000Z

Sentiment: neutral

Topics: 8-K, regulatory-filing

TL;DR

DaVita filed an 8-K on 4/14 for events on 4/12 - details TBD.

AI Summary

DaVita Inc. filed an 8-K on April 14, 2025, reporting other events that occurred on April 12, 2025. The filing does not specify the nature of these events but is a current report under the Securities Exchange Act of 1934.

Why It Matters

This filing indicates DaVita Inc. has reported significant events to the SEC, which could impact investors' understanding of the company's current operations or strategic direction.

Risk Assessment

Risk Level: medium — The filing is a standard 8-K for 'Other Events,' which can range from routine disclosures to significant, unannounced developments, requiring further investigation.

Key Players & Entities

FAQ

What specific 'Other Events' are being reported by DaVita Inc. in this 8-K filing?

The filing does not specify the nature of the 'Other Events' beyond stating that it is a current report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.

When was the earliest event reported in this 8-K filing?

The earliest event reported in this 8-K filing occurred on April 12, 2025.

What is DaVita Inc.'s Central Index Key (CIK)?

DaVita Inc.'s Central Index Key (CIK) is 0000927066.

What is the address of DaVita Inc.'s principal executive offices?

The address of DaVita Inc.'s principal executive offices is 2000 16th Street, Denver, CO 80202.

What is the filing date of this 8-K report?

This 8-K report was filed on April 14, 2025.

From the Filing

0001193125-25-079593.txt : 20250414 0001193125-25-079593.hdr.sgml : 20250414 20250414065400 ACCESSION NUMBER: 0001193125-25-079593 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20250412 ITEM INFORMATION: Other Events FILED AS OF DATE: 20250414 DATE AS OF CHANGE: 20250414 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DAVITA INC. CENTRAL INDEX KEY: 0000927066 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 510354549 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-14106 FILM NUMBER: 25834180 BUSINESS ADDRESS: STREET 1: 2000 16TH STREET CITY: DENVER STATE: CO ZIP: 80202 BUSINESS PHONE: 310-536-2668 MAIL ADDRESS: STREET 1: 2000 16TH STREET CITY: DENVER STATE: CO ZIP: 80202 FORMER COMPANY: FORMER CONFORMED NAME: DAVITA HEALTHCARE PARTNERS INC. DATE OF NAME CHANGE: 20121107 FORMER COMPANY: FORMER CONFORMED NAME: DAVITA INC DATE OF NAME CHANGE: 20001005 FORMER COMPANY: FORMER CONFORMED NAME: TOTAL RENAL CARE HOLDINGS INC DATE OF NAME CHANGE: 19950524 8-K 1 d948299d8k.htm 8-K 8-K false 0000927066 0000927066 2025-04-12 2025-04-12     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549     Form 8-K     CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): April 12, 2025     DAVITA INC. (Exact name of registrant as specified in its charter)       DE   1-14106   51-0354549 (State or other jurisdiction of incorporation)   (Commission File Number)   (IRS Employer Identification No.)   2000 16th Street Denver , CO 80202 (Address of principal executive offices including Zip Code) (720) 631-2100 (Registrant’s telephone number, including area code) Not applicable (Former name or former address, if changed since last report)     Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 240.425)   ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:   Title of each class:   Trading symbol(s):   Name of each exchange on which registered: Common Stock, $0.001 par value   DVA   New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).   ☐ Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐       Item 8.01. Other Events. On April 12, 2025, DaVita Inc. (the “Company” or “we”) became aware of a ransomware incident that has encrypted certain elements of our network. Upon discovery, we activated our response protocols and implemented containment measures, including proactively isolating impacted systems. We are actively working to assess and remediate the incident with the assistance of third-party cybersecurity professionals and have notified law enforcement of the matter. We have im

View on Read The Filing